External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ACAAI 2022

-
Coming soon
04:30 PM
Duration 10mins Kentucky International Convention Center
Patients With Chronic Spontaneous Urticaria May Benefit From Longer Treatment Or Updosing With Omalizumab
Mosnaim G, Casale T, Holden M, Trzaskoma B, Bernstein J

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar